Naba Alsaha Medical Services Company
TADAWUL:9546.SR
78.5 (SAR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 9 | 9 | 5.746 | 5.746 | 8.795 | 8.795 | 13.826 | 13.826 | 8.275 | 8.275 | 6.994 | 6.994 | -1.786 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.572 |
Cash and Short Term Investments
| 9 | 9 | 5.746 | 5.746 | 8.795 | 8.795 | 13.826 | 13.826 | 8.275 | 8.275 | 6.994 | 6.994 | 1.786 |
Net Receivables
| 97.26 | 97.26 | 107.799 | 106.939 | 84.121 | 83.679 | 58.243 | 57.541 | 64.699 | 64.699 | 60.803 | 60.12 | 0 |
Inventory
| 11.644 | 11.644 | 12.02 | 9.98 | 11.712 | 11.712 | 5.49 | 5.49 | 7.135 | 7.135 | 7.071 | 5.754 | 0 |
Other Current Assets
| 0.365 | 0.365 | 0.906 | 3.806 | 2.449 | 2.89 | 0.493 | 1.699 | 2.745 | 2.745 | 0.619 | 2.619 | 0 |
Total Current Assets
| 120.757 | 120.757 | 126.47 | 126.47 | 107.076 | 107.076 | 78.557 | 78.557 | 82.853 | 82.853 | 75.487 | 75.487 | 1.786 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 159.456 | 159.456 | 144.009 | 144.009 | 114.258 | 114.258 | 85.989 | 85.989 | 79.639 | 79.639 | 80.386 | 80.386 | 0 |
Goodwill
| 2.269 | 0 | 2.269 | 2.269 | 2.269 | 2.269 | 2.269 | 2.269 | 2.269 | 2.269 | 2.269 | 2.269 | 0 |
Intangible Assets
| 3.23 | 3.23 | 0.984 | 0.984 | 1.057 | 1.057 | 0.981 | 0.981 | 2.269 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 3.23 | 3.23 | 3.253 | 3.253 | 3.325 | 3.325 | 3.25 | 3.25 | 2.269 | 2.269 | 2.269 | 2.269 | 0 |
Long Term Investments
| 2.372 | 2.372 | 2.986 | 2.986 | 2.394 | 2.394 | 2.702 | 2.702 | 2.829 | 2.829 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | -0.984 | 0 | -2.394 | 0 | -2.702 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0.984 | 0 | 2.394 | 0 | 2.702 | 0 | 0 | 0 | 0 | 0 | -1.786 |
Total Non-Current Assets
| 165.058 | 165.058 | 150.248 | 150.248 | 119.976 | 119.976 | 91.94 | 91.94 | 84.737 | 84.737 | 82.655 | 82.655 | -1.786 |
Total Assets
| 285.815 | 285.815 | 276.718 | 276.718 | 227.053 | 227.053 | 170.497 | 170.497 | 167.591 | 167.591 | 158.142 | 158.142 | 0 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 10.52 | 10.52 | 21.804 | 21.804 | 9.319 | 9.319 | 4.654 | 4.654 | 7.451 | 7.451 | 6.734 | 6.734 | 0 |
Short Term Debt
| 8.75 | 8.75 | 10.423 | 8.75 | 9.996 | 16.225 | 10.271 | 8.75 | 5.016 | 3.5 | 2.239 | 8.75 | 0 |
Tax Payables
| 0 | 0 | 3.103 | 0 | 1.772 | 0 | 1.09 | 0 | 1.192 | 0 | 2.01 | 0 | 0 |
Deferred Revenue
| 1.749 | 1.749 | 3.103 | 0 | 0 | 0 | 4.829 | 0 | 1.192 | 0 | 4.11 | 0 | 0 |
Other Current Liabilities
| 3.083 | 4.832 | -14.329 | -6.449 | 15.888 | 11.431 | -4.818 | 2.621 | -1.205 | 2.696 | -3.67 | 3.94 | 0 |
Total Current Liabilities
| 34.621 | 34.621 | 45.908 | 45.908 | 46.294 | 46.294 | 20.68 | 20.68 | 21.098 | 21.098 | 18.158 | 26.158 | 0 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 40.613 | 40.613 | 34.313 | 37.769 | 11.616 | 11.616 | 11.8 | 11.8 | 17.5 | 21.519 | 26.25 | 23.054 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 17.443 | 17.443 | 16.403 | 12.947 | 13.456 | 13.456 | 8 | 8 | 10.738 | 6.719 | 10.872 | 6.068 | 0 |
Total Non-Current Liabilities
| 58.056 | 58.056 | 50.716 | 50.716 | 25.072 | 25.072 | 19.8 | 19.8 | 28.238 | 28.238 | 37.122 | 29.122 | 0 |
Total Liabilities
| 92.677 | 92.677 | 96.624 | 96.624 | 71.366 | 71.366 | 40.479 | 40.479 | 49.336 | 49.336 | 55.28 | 55.28 | 0 |
Equity: | |||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 105 | 105 | 105 | 105 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 0 |
Retained Earnings
| 86.675 | 86.675 | 60.769 | 73.632 | 71.156 | 84.018 | 45.487 | 58.349 | 36.649 | 46.82 | 21.256 | 31.427 | 0 |
Accumulated Other Comprehensive Income/Loss
| 1.463 | 1.463 | 14.325 | 1.463 | 14.531 | 1.668 | 14.531 | 1.668 | 11.606 | 1.435 | 11.606 | 1.435 | 78.398 |
Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Equity
| 193.138 | 193.138 | 180.094 | 180.094 | 155.687 | 155.687 | 130.018 | 130.018 | 118.255 | 118.255 | 102.862 | 102.862 | 78.398 |
Total Equity
| 193.138 | 193.138 | 180.094 | 180.094 | 155.687 | 155.687 | 130.018 | 130.018 | 118.255 | 118.255 | 102.862 | 102.862 | 78.398 |
Total Liabilities & Shareholders Equity
| 285.815 | 285.815 | 276.718 | 276.718 | 227.053 | 227.053 | 170.497 | 170.497 | 167.591 | 167.591 | 158.142 | 158.142 | 78.398 |